Cancer Guardian powered by Wamberg Genomic Advisors, Inc.

    About the Company
    Company Details
    • Website
      https://www.cancerguardian.com
    • Primary Contact Name
      Nick Bellanca
    Solution Details
    • Target Employer Size
      Small (1-99), Mid-market (100 to 999), Large (1000-4999), Enterprise (5000+)
    • Company Funding Level
      Private Investors and Series A concluded in 2019 and Series B in 2020.
    • Firms That Have Invested
      Private Investors
    • Planning On Seeking Funding?
      Yes
    • What Size is the Company?
      30
    Competition Breakdown
    • Main Competitors
      N/A
    • Company Competitive Advantage
      First mover and a very unique team with deep experience in genetics, group insurance, life insurance, cancer services, and medical expertise.
    Additional Downloadable Documentation
    Cost Model
    • Pricing Structure
      PEPM
    • Initial Fees
      NA
    • Are There Ongoing Fees?
      NA
    • Average Annual Contract Value
      1,100 eligible lives
    • Broker Compensation Available
      Yes. Flat and Heaped comp options
    Distribution Model
    • Brokers (B2B)
      Yes
    • Employers (B2B)
      Yes
    • Individuals (B2C)
      No
    Technology Details
    • Security / HIPAA Information
      SOC2 Completed and HIPAA compliant
    Team Construct
    • Number of Employees
      30
    • Employee Growth Over Last Year
      30%
    Leadership
    • History/Heritage
      https://www.wamberggenomic.com/our-team/
    Financial Details
    • Number of Current Clients
      190+
    • Years in Service
      3
    • Sales to Date (or since launch)
      190+
    • Sales in Last Year
      170+
    Diversity
    • Is this a Public of Private Company?
      Private
    • Does the Organization have a Diversity Inclusion Policy
      NA
    chat
    Add a review
    keyboard_arrow_up